Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07610577 · ClinicalTrials.gov registry record
Use and Costs of P2Y12 Inhibitors After Acute Myocardial Infarction
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 377,753
- Enrollment target
NCT07610577 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 377,753 participants.
The verdict
NCT07610577 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 377,753 participants
- Enrollment target
Study Summary
This study aims to describe temporal trends in the use and costs of clopidogrel, ticagrelor, and prasugrel in Germany and the United States.
Interventions
- DRUG Clopidogrel
- DRUG Prasugrel
- DRUG Ticagrelor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 377,753 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2026-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07610577
The ClinicalTrials.gov registry entry for NCT07610577 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 377,753 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Clopidogrel is the first listed.
NCT07610577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07610577 about?
NCT07610577 is a clinical study titled "Use and Costs of P2Y12 Inhibitors After Acute Myocardial Infarction". This study aims to describe temporal trends in the use and costs of clopidogrel, ticagrelor, and prasugrel in Germany and the United States.
What is the current status of trial NCT07610577?
This trial is currently completed. The enrollment target is 377,753 participants. The study started on 2025-11-01. Estimated completion is 2026-05-31.
What interventions are being tested in trial NCT07610577?
The interventions under investigation include: Clopidogrel (DRUG), Prasugrel (DRUG), Ticagrelor (DRUG).
Who is sponsoring clinical trial NCT07610577?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.